Chartwell Investment Partners’s DexCom DXCM Stock Holding History

Chartwell Investment Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$761K	Hold	11,356	–	–	0.03%	372
2024 Q2	$1.29M	Buy	11,356 +1,653	+17%	+$209K	0.05%	321
2024 Q1	$1.35M	Buy	9,703 +3,513	+57%	+$442K	0.05%	334
2023 Q4	$768K	Sell	6,190 -5,900	-49%	-$603K	0.03%	381
2023 Q3	$1.13M	Sell	12,090 -18,317	-60%	-$2.06M	0.04%	344
2023 Q2	$3.91M	Buy	30,407 +5,553	+22%	+$672K	0.14%	224
2023 Q1	$2.89M	Buy	24,854 +37	+0.1%	+$4.14K	0.11%	243
2022 Q4	$2.81M	Sell	24,817 -40	-0.2%	-$4.39K	0.11%	238
2022 Q3	$2M	Buy	24,857 +20,006	+412%	+$1.69M	0.09%	267
2022 Q2	$361K	Buy	4,851 +19	+0.4%	+$1.73K	0.01%	405
2022 Q1	$618K	Hold	4,832	–	–	0.02%	398
2021 Q4	$649K	Hold	4,832	–	–	0.02%	402
2021 Q3	$660K	Hold	4,832	–	–	0.02%	401
2021 Q2	$516K	Hold	4,832	–	–	0.02%	409
2021 Q1	$434K	Hold	4,832	–	–	0.01%	404
2020 Q4	$447K	Hold	4,832	–	–	0.01%	408
2020 Q3	$498K	Buy	4,832 +256	+6%	+$26.7K	0.02%	394
2020 Q2	$464K	Buy	4,576 +204	+5%	+$18.2K	0.02%	380
2020 Q1	$294K	Hold	4,372	–	–	0.01%	381
2019 Q4	$239K	Buy	+4,372	New	+$207K	0.01%	403

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Chartwell Investment Partners's DXCM Position: Q3 2024 in Review

Chartwell Investment Partners held its DexCom (DXCM) position steady in Q3 2024 at 11,356 shares worth $761K. The position accounts for 0.03% of the portfolio, ranked #372.

Chartwell Investment Partners first reported a position in DXCM in Q4 2019 and has held it in 20 quarters since. The position peaked at $3.91M in Q2 2023. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

Chartwell Investment Partners held 11,356 shares of DexCom worth $761K as of Q3 2024.
Chartwell Investment Partners left its DexCom share count unchanged in Q3 2024.
DexCom made up 0.03% of Chartwell Investment Partners's portfolio in Q3 2024, its #372 holding.
Chartwell Investment Partners first reported a position in DexCom in Q4 2019 and has held it in 20 quarters since.
Chartwell Investment Partners's DexCom position peaked at $3.91M in Q2 2023.
889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.